3rd Quarter - Report

THE NICKLES GROUP, LLC for MERCK & CO. INC.

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to drug pricing and the Medicare Part D program.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP)

Health Issues HCR

Issues related to antimicrobials; issues related to the reauthorization of PAHPA, including S. 2852 / H.R. 6378, Pandemic All Hazards Preparedness Act of 2018; monitored issues related to H.R. 5554, The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (ADUFA) and (AGDUFA). Issues regarding drug pricing.

LobbyistCovered position, as disclosed
STEPHANIE BADGER —
STACEY HUGHES —
EMILY PORTER —

Contacted: SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 2852 (115th), H.R. 5554 (115th), H.R. 6378 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.